| Product Code: ETC9971378 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neurology Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neurology Market - Industry Life Cycle |
3.4 United States (US) Neurology Market - Porter's Five Forces |
3.5 United States (US) Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Neurology Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 United States (US) Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 United States (US) Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in the US population |
4.2.2 Technological advancements in neurology diagnostics and treatment |
4.2.3 Growing awareness and focus on mental health and neurological well-being |
4.3 Market Restraints |
4.3.1 High cost of neurology treatments and medications |
4.3.2 Shortage of neurologists and healthcare professionals specializing in neurology |
4.3.3 Regulatory challenges and approval processes for new neurology drugs and therapies |
5 United States (US) Neurology Market Trends |
6 United States (US) Neurology Market, By Types |
6.1 United States (US) Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neurology Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Neurology Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.4 United States (US) Neurology Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.5 United States (US) Neurology Market Revenues & Volume, By Neuro-infectious Diseases, 2021- 2031F |
6.1.6 United States (US) Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Neurology Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neurology Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.3 United States (US) Neurology Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.2.4 United States (US) Neurology Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.5 United States (US) Neurology Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.6 United States (US) Neurology Market Revenues & Volume, By Stroke, 2021- 2031F |
6.2.7 United States (US) Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Neurology Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neurology Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 United States (US) Neurology Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 United States (US) Neurology Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Neurology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Neurology Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United States (US) Neurology Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 United States (US) Neurology Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.6 United States (US) Neurology Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Neurology Market Import-Export Trade Statistics |
7.1 United States (US) Neurology Market Export to Major Countries |
7.2 United States (US) Neurology Market Imports from Major Countries |
8 United States (US) Neurology Market Key Performance Indicators |
8.1 Number of research studies and clinical trials in neurology conducted in the US |
8.2 Adoption rate of telemedicine and digital health solutions in neurology practices |
8.3 Patient satisfaction scores and outcomes improvement in neurology treatments |
8.4 Investment in neurology RD and innovation by pharmaceutical companies |
8.5 Number of neurology conferences and events held in the US. |
9 United States (US) Neurology Market - Opportunity Assessment |
9.1 United States (US) Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Neurology Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 United States (US) Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 United States (US) Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Neurology Market - Competitive Landscape |
10.1 United States (US) Neurology Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here